Clinical Trials Symposium

• Compare and Contrast Guidelines for Drug Development in RA and OA
• Most Common Reasons For Screen Failure In Clinical Trials Of Knee Osteoarthritis – Analysis Of Eight Phase II Trials - Andrea Kaaber
• Overview of the Clinical Developments in the Field
• Regulatory Round Table
• Regulatory Understanding and Current Guidelines in the EU and US – Implications for OA Trial Design